{
    "applicationNumber": "BR 11 2022 015832-7",
    "filingDate": "12/02/2021",
    "grantDate": null,
    "title": "MOL\u00c9CULA DE ANTICORPO, SEQU\u00caNCIA DE NUCLEOT\u00cdDEOS ISOLADA, PLASM\u00cdDEO, C\u00c9LULA, USO DE UMA MOL\u00c9CULA DE ANTICORPO, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, E, M\u00c9TODO PARA TRATAMENTO DE REJEI\u00c7\u00c3O DE ENXERTO, UM DIST\u00daRBIO AUTOIMUNE E/OU UM DIST\u00daRBIO INFLAMAT\u00d3RIO",
    "nationalPhaseDate": [
        "10/08/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2021/053516",
        "pctDate": "12/02/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "EP",
            "priorityNumber": "20156969.6",
            "priorityDate": "12/02/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2694"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2703"
        }
    ],
    "inventors": [
        "BJ\u00d6RN FRENDEUS",
        "ALI ROGHANIAN",
        "MARK CRAGG"
    ],
    "holders": [
        268753,
        111330
    ],
    "ipcCodes": [
        "A61K 39/00",
        "C07K 16/28"
    ]
}